Rosacea References

2. Stevens G, Lemp M. Acne rosacea. In: T Weingeist , D Gould. The Eye in Systemic Disease. Philadelphia: Lippincott, 1990.

3. Jenkins MS, Brown SI, Lempert SL, Weinberg RJ. Ocular rosacea. In: BD Srinivasan. Ocular therapeutics. New York: Masson Publishing, 1980.

4. Starr PAH, McDonald A. Oculocutaneous aspects of rosacea. Proc R Soc Med. 1969;62:9.

5. Marks R. Concepts in the pathogenesis of rosacea. Br J Dermatol. 1968;80:170.

6. Borrie P. Rosacea with special reference to its ocular manifestations. Br J Ophthalmol. 1953;65:458.

7. Brauner GJ. Cutaneous disease in black races. In: SL Moschella , HJ Hurley. Dermatology. Philadelphia: W.B. Saunders, 1985.

8. Browning DJ, Rosenwasser G, Lugo M. Ocular rosacea in blacks. Am J Ophthalmol. 1986;101:441-444.

9. Rosen T, Stone MS. Acne rosacea in blacks. J Am Acad Dermatol. 1987;17:70-73.

10. Marks R. Rosacea, flushing and perioral dermatitis. In: RH Champion, JL Burton , FJG Ebling. Textbook of Dermatology. London: Blackwell Scientific Publications, 1993.

11. Wilkin JK. Epigastric rosacea. Arch Dermatol. 1980;116:584.

12. Marks R, Jones EW. Disseminated rosacea. Br J Dermatol. 1969;81:16.

13. Irvine C, Marks R. Prognosis and prognostic factors in rosacea. In: R Marks , G Plewig. Acne and related disorders. London: Martin Dunitz, 1989.

14. Browning DJ, Proia AD. Ocular Rosacea. Surv Ophthalmol. 1986;31:145-158.

15. Jenkins MA, Brown SI, Lempert SL, al. e. Ocular rosacea. Am J Ophthalmol. 1979;88:618-622.

16. Lempert SL, Jenkins MS, Brown SI. Chalazia and rosacea. Arch Ophthalmol. 1979;97:1652.

17. Wise G. Ocular rosacea. Am J Ophthalmol. 1943;26:591-609.

18. Doggart JH. The ocular complications of acne rosacea. Br J Ophthalmol. 1931;15:446-457.

19. Foster CS. Ocular surface manifestations of neurological and systemic disease. Int Ophthalmol Clin. 1979;69:207-242.

20. Lemp M, Mahmood MA, Weiler HH. Association of rosacea in keratoconjunctivitis sicca. Arch Ophthalmol. 1984;102:556.

21. Thygeson P. Dermatoses with ocular manifestations. In: A Sorsby. Systemic ophthalmology. London: Butterworth, 1951.

22. Goldsmith AJB. The ocular manifestations of rosacea. Br J Dermatol. 1953;

23. Richter S. Skleraperforation bei rosaceokeratitis. Klin Monatsbl Augenheillkd. 1965;146:422-424.

24. Rebora A. Rosacea. J Invest Dermatol. 1987;88:56s-60s.

25. Spickett P. Aetiology of rosacea. Br Med J. 1962;i:1625-1626.

26. Russell BF. Some aspects of the biology of the epidermis. Br Med J. 1962;i:815-820.

27. Rufli T, Buchner SA. T-cell subsets in acne rosacea lesions and the possible role of demodex folliculorum. Dermatologica. 1984;169:1.

28. Marks R, Harcourt-Webster JN. Histopathology of rosacea. Arch Dermatol. 1969;100:682.

29. Nunzi E, Rebora A, Hamerlinck F, al. e. Immunopathological studies on rosacea. Br J Dermatol. 1980;103:543.

30. Marks R. Histogenesis of the inflammatory component of rosacea. Proc Roy Soc Med. 1973;66:742-745.

31. McCulley JP, Sciallis GF. Meibomian keratoconjunctivitis. Am J Ophthalmol. 1977;84:788.

32. Wilkin JK. Rosacea. Int J Dermatol. 1983;22:343.

33. Smolin G, Okumoto M. Staphylococcal blepharitis. Arch Ophthalmol. 1977;95:812-816.

34. Mondino BJ. Inflammatory diseases of the peripheral cornea. Ophthalmol. 1988;95:463-472.

35. Pochi PE. Acne rosacea. In: DJ Demis. Clinical Dermatology. Philadelphia: J.B. Lippincott Company, 1991.

36. Manna V, Marks R, Holt P. Involvement of immune mechanisms in the pathogenesis of rosacea. Br J Dermatol. 1982;107:203.

37. Leyden JJ, Thew M, Klingman AM. Steroid rosacea. Arch Dermatol. 1974;110:619.

38. Sneddon I, 1966. A clinical trial of tetracycline in rosacea. Br J Dermatol. 1966;78:649-653.

39. Wereide K. Long tern treatment of rosacea with oral tetracycline. Acta Derm Venereol. 1969;49:176-179.

40. Marmion VJ. Tetracyclines in the treatment of ocular rosacea. Proc Roy Soc Med. 1969;62:11-12.

41. Shalita AR, Cunningham WJ, Leyden JJ. Isotretinoin treatment of acne and related disorders: an update. J Am Acad Dermatol. 1983;9:629-683.

42. Plewig G, Nikolowski J, Wolff H. Action of isotretinoin in acne rosacea and gram negative foliculitis. J Am Acad Dermatol. 1982;6:7676-785.

43. Hoting E, Paul E, Plewig G. Treatment of rosacea with isotretinoin. Int J Dermatol. 1986;25:660-663.

44. Cunliffe JW, Dodman B, Binner JG. Clonidine and facial flushing in rosacea. Br Med J. 1977;1:105. 45. Nielsen PG. A double-blind study of 1% metronidazole cream versus systemic oxytetracycline therapy for rosacea. Br J Dermatol. 1983;109:63.

46. Bleicher PA, Charles JG, Sober AJ. Topical metronidazole therapy for rosacea. Arch Dermatol. 1987;123:609-614.

47. Aronson IK, Rumsfeld JA, West DP, al. e. Evaluation of topical metronidazole gel in acne rosacea. Drug Intell Clin Pharmacol. 1987;21:346-351.

48. Sneddon I. Adverse effect of topical fluorinated corticosteroids in rosacea. Br Med J. 1969;1:671.

49. Polla LL, Tan OT, Garden JM, al. e. Tunable pulsed dye laser for the treatment of benign cutaneous vascular ectasia. Dermatologica. 1987;174:11-17.

50. Pastorek MJ. The management of rhinophyma. Otolaryngol Clin North Am. 1972;5:639-646.

51. Verde SF. How we treat rhinophyma. J Dermatol Surg Oncol. 1980;6:560.

52. Henning JPH, Gemert MJC. Rhinophyma treated by argon laser. Lasers Surg Med. 1983;2:211.

53. Shapshay SM, al. e. Removal of rhinophyma with the carbon dioxide laser. Arch Otolaryngol. 1980;106:257.

54. Frucht-Pery, Chayet AS, Feldman ST, Lin S, Brown SI. The effect of doxycycline on ocular rosacea. Am J Ophthalmol.1989;107:434-435.

55. Frucht-Pery J, Sagi E, Hemo I, Ever-Hadani P. Efficacy of doxycyline and tetracycline in ocular rosacea. Am J Ophthalmol. 1993;116:88-92.

56. Bartholomew RS, Reid BJ, MacDonald M, Galloway NR. Oxytetracycline in the treatment of ocular rosacea: a double-blind trial. Br J Ophthalmol. 1982;66:386.

57. Salamon SM. Tetracyclines in ophthalmology. Surv Ophthalmol. 1985;29:265-275.

58. Hyndiuk RA, Chin GN. Corticosteroid therapy in corneal disease. Int Ophthalmol Clin. 1973;13:103-123.